Atrial natriuretic peptide regulates lipid mobilization and oxygen consumption in human adipocytes by activating AMPK

Biochemical and Biophysical Research Communications

Volumn 410, Issue 3, 2011, Pages 398-403

  Souza, Sandra C ^a   Chau, Mary D L ^a   Yang, Qing ^a   Gauthier, Marie Soleil ^b   Clairmont, Kevin B ^a   Wu, Zhidan ^a   Gromada, Jesper ^a   Dole, William P ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AMP activated protein kinase (AMPK); Atrial natriuretic peptide (ANP); Human adipocytes; Lipolysis; Oxygen consumption

Indexed keywords

ADENYLATE KINASE; ATRIAL NATRIURETIC FACTOR; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1A; CYTOCHROME C; FATTY ACID; LIPID; OXYGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOCYTES; AMP-ACTIVATED PROTEIN KINASES; ATRIAL NATRIURETIC FACTOR; CELLS, CULTURED; ENZYME ACTIVATION; GENE EXPRESSION; GENES, MITOCHONDRIAL; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; OXYGEN CONSUMPTION;

EID: 79960044661     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.143     Document Type: Article

References (29)

1. Molkentin J.D. A friend within the heart: natriuretic peptide receptor signaling. J. Clin. Invest. 2003, 111:1275-1277.
2. Lafontan M., Moro C., Sengenes C., Galitzky J., Crampes F., Berlan M. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2032-2042.
3. Birkenfeld A.L., Boschmann M., Jordan J. Metabolic regulation: effects of natriuretic peptide interactions. Expert Rev. Endocrinol. Metabol. 2007, 2:607-614.
4. Sengenes C., Berlan M., De Glisezinski I., Lafontan M., Galitzky J. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J. 2000, 14:1345-1351.
5. Moro C., Polak J., Hejnova J., Klimcakova E., Crampes F., Stich V., Lafontan M., Berlan M. Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exercise. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E864-E869.
6. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Wilson P.W., Vasan R.S. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004, 109:594-600.
7. Wang T.J., Larson M.G., Keyes M.J., Levy D., Benjamin E.J., Vasan R.S. Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 2007, 115:1345-1353.
8. Sarzani R., Strazzullo P., Salvi F., Iacone R., Pietrucci F., Siani A., Barba G., Gerardi M.C., Dessi-Fulgheri P., Rappelli A. Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity. Obes. Res. 2004, 12:351-356.
9. Miyashita K., Itoh H., Tsujimoto H., Tamura N., Fukunaga Y., Sone M., Yamahara K., Taura D., Inuzuka M., Sonoyama T., Nakao K. Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 2009, 58:2880-2892.
10. Lafontan M., Moro C., Berlan M., Crampes F., Sengenes C., Galitzky J. Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol. Metab. 2008, 19:130-137.
11. Sengenes C., Bouloumie A., Hauner H., Berlan M., Busse R., Lafontan M., Galitzky J. Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J. Biol. Chem. 2003, 278:48617-48626.
12. Bourron O., Daval M., Hainault I., Hajduch E., Servant J.M., Gautier J.F., Ferre P., Foufelle F. Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase. Diabetologia 2010, 53:768-778.
13. Y.Q. Souza SC, Clairmont K, Dole WP, Metabolic Role of Atrial Natriuretic Peptide in Human Adipocytes, American Diabetes Association, New Orleans, LA, 2009.
14. X.G. Cao, C.Z. Kou, Y.P. Zhao, C.L. Gao, C. Zhu, C.M. Zhang, C.B. Ji, D.N. Qin, M. Zhang, X.R. Guo, Overexpression of LYRM1 induces mitochondrial impairment in 3T3-L1 adipocytes, Mol. Genet. Metab. (2010).
15. Ren J., Pulakat L., Whaley-Connell A., Sowers J.R. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J. Mol. Med. 2010, 88:993-1001.
16. L. Yuzefovych, G. Wilson, L. Rachek, Different effects of oleate versus palmitate on mitochondrial function, apoptosis and insulin signaling in L6 skeletal muscle cells: role of oxidative stress, Am. J. Physiol. Endocrinol. Metab. (2010).
17. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 2001, 108:1167-1174.
18. Fryer L.G., Parbu-Patel A., Carling D. The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 2002, 277:25226-25232.
19. Narkar V.A., Downes M., Yu R.T., Embler E., Wang Y.X., Banayo E., Mihaylova M.M., Nelson M.C., Zou Y., Juguilon H., Kang H., Shaw R.J., Evans R.M. AMPK PPARdelta agonists are exercise mimetics. Cell 2008, 134:405-415.
20. Garton A.J., Campbell D.G., Carling D., Hardie D.G., Colbran R.J., Yeaman S.J. Phosphorylation of bovine hormone-sensitive lipase by the AMP-activated protein kinase. A possible antilipolytic mechanism. Eur. J. Biochem. 1989, 179:249-254.
21. Daval M., Diot-Dupuy F., Bazin R., Hainault I., Viollet B., Vaulont S., Hajduch E., Ferre P., Foufelle F. Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes. J. Biol. Chem. 2005, 280:25250-25257.
22. Djouder N., Tuerk R.D., Suter M., Salvioni P., Thali R.F., Scholz R., Vaahtomeri K., Auchli Y., Rechsteiner H., Brunisholz R.A., Viollet B., Makela T.P., Wallimann T., Neumann D., Krek W. PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis. EMBO J. 2010, 29:469-481.
23. Grisouard J., Timper K., Radimerski T.M., Frey D.M., Peterli R., Kola B., Korbonits M., Herrmann P., Krahenbuhl S., Zulewski H., Keller U., Muller B., Christ-Crain M. Mechanisms of metformin action on glucose transport and metabolism in human adipocytes. Biochem. Pharmacol. 2010, 80:1736-1745.
24. Gaidhu M.P., Fediuc S., Anthony N.M., So M., Mirpourian M., Perry R.L., Ceddia R.B. Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL. J. Lipid Res. 2009, 50:704-715.
25. Sarzani R., Salvi F., Dessi-Fulgheri P., Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J. Hypertens. 2008, 26:831-843.
26. Birk J.B., Wojtaszewski J.F. Predominant alpha2/beta2/gamma3 AMPK activation during exercise in human skeletal muscle. J. Physiol. 2006, 577:1021-1032.
27. Moro C., Crampes F., Sengenes C., De Glisezinski I., Galitzky J., Thalamas C., Lafontan M., Berlan M. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB J. 2004, 18:908-910.
28. Moro C., Pillard F., De Glisezinski I., Harant I., Riviere D., Stich V., Lafontan M., Crampes F., Berlan M. Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men. Med. Sci. Sports Exerc. 2005, 37:1126-1132.
29. Moro C., Pillard F., de Glisezinski I., Klimcakova E., Crampes F., Thalamas C., Harant I., Marques M.A., Lafontan M., Berlan M. Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E505-E513.